Alaunos Therapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Alaunos Therapeutics, Inc. (TCRT) had Operating Lease, Weighted Average Discount Rate, Percent of 0.00% as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2025-03-31
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 0.00%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 0.00%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 8.26%.
- 2021-12-31: Operating Lease, Weighted Average Discount Rate, Percent 8.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2024-12-31 | 0.00% 10-K · filed 2025-03-31 |
| 2023-12-31 | 0.00% 10-K · filed 2025-03-31 |
| 2022-12-31 | 8.26% 10-K · filed 2024-04-01 |
| 2021-12-31 | 8.00% 10-K · filed 2023-03-07 |
| 2021-09-30 | 8.00% 10-Q · filed 2021-11-08 |
| 2021-06-30 | 8.00% 10-Q · filed 2021-08-13 |
| 2021-03-31 | 8.00% 10-Q · filed 2021-05-06 |
| 2020-12-31 | 8.00% 10-K · filed 2022-03-30 |
| 2020-09-30 | 8.00% 10-Q · filed 2021-11-08 |
| 2020-06-30 | 8.00% 10-Q · filed 2021-08-13 |
| 2020-03-31 | 8.00% 10-Q · filed 2020-05-07 |
| 2019-12-31 | 8.00% 10-K · filed 2021-03-01 |
| 2019-09-30 | 8.00% 10-Q · filed 2020-11-05 |
| 2019-06-30 | 8.00% 10-Q · filed 2020-08-06 |
| 2019-03-31 | 8.00% 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |